INSIGHTEC, founded in 1999, is a trailblazing company in the Biotechnology and Medical Devices industry. With headquarters in Haifa, Israel, and Miami, Florida, and additional offices in strategic locations like Dallas, Shanghai, and Tokyo, the company is well-positioned globally. INSIGHTEC is reshaping patient care by employing acoustic energy for noninvasive medical treatments through their flagship Exablate Neuro platform.
The platform utilizes focused sound waves, precisely guided by MRI, for treating medication-resistant Essential Tremor and Parkinson's Disease. Active research partnerships with leading academic institutions suggest strong potential for expanding applications within neuroscience.
In its latest funding round on 01 June 2024, INSIGHTEC attracted a late VC investment of $150 million from prominent investors including Ally Bridge Group, Baillie Gifford, and Fidelity Investments. These partnerships highlight robust investor confidence and position INSIGHTEC for continued innovation and market expansion.